April 05, 2025 04:02 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Huge protests erupt in Kolkata, Chennai after parliament passes Waqf Amendment Bill | India’s growth outlook dims after US tariffs; deeper rate cuts likely, say analysts: Report | K Annamalai says he is not in a race to become Tamil Nadu BJP's next president | PM Modi meets Muhammad Yunus in Bangkok amid bilateral tension in first since Hasina's fall | Calcutta HC blasts TMC leader-headed film federation over infringement of directors' fundamental rights | BJP demands Mamata Banerjee's resignation over Supreme Court verdict quashing Bengal govt jobs | Rajya Sabha passes Waqf (Amendment) Bill 2025 after marathon debate, 128 voted in favour | West Bengal: Mamata Banerjee accuses BJP, CPI (M) for SC verdict on SSC recruitment, vows to support affected teachers | Supreme Court stays deforestation in Hyderabad's Kancha Gachibowli amid protests | Modi a great friend of mine but not treating US right: Donald Trump announcing reciprocal tariffs on India
Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

May 21, 2021, at 08:05 pm

London: Two doses of the  AstraZeneca Plc's Covid-19 vaccine is providing   around 85 to 90% protection against symptomatic disease, as per statistics released by Public Health England on Thursday.

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

Two AstraZeneca COVID-19 doses give upto 90 percent protection against symptomatic disease: Study

May 21, 2021, at 05:15 pm

London: Two doses of the  AstraZeneca Plc's Covid-19 vaccine is providing   around 85 to 90% protection against symptomatic disease, as per statistics released by Public Health England on Thursday.

India commits to ship Covishield vaccines to Canada within a month

India commits to ship Covishield vaccines to Canada within a month

Feb 16, 2021, at 04:46 am

Canada/IBNS: Adar Poonawalla, the chief executive of Serum Institute of India (SII), confirmed on Monday that Covishield vaccines would be shipped to Canada within a month.

After DCGI's show-cause notice, Serum Institute pauses Covid-19 vaccine trial

After DCGI's show-cause notice, Serum Institute pauses Covid-19 vaccine trial

Sep 10, 2020, at 11:14 pm

New Delhi/IBNS: Serum Institute of India (SII) on Thursday paused the trial of Covid-19 vaccine a day after it was served a show-cause notice by the Drugs Controller General of India (DCGI) for not informing the central drug regulator about the pause of study testing in other countries, media reports said.

Close menu